Naltrexone Accord (Naltrexone Hydrochloride)

Naltrexone acts as a competitive antagonist at the mu‑opioid receptors in the central nervous system, preventing endogenous and exogenous opioids from activating the receptor, thereby diminishing dopamine‑mediated reward pathways associated with alcohol and opioid use.

The dosage regimen for Naltrexone Accord is determined by the prescribing clinician based on the individual’s condition, treatment goals, and clinical response. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for Naltrexone in pregnancy and lactation are limited; therefore, it should only be used when the potential benefit justifies the potential risk to the fetus or infant, and the decision should be made by a qualified health professional.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with opioid agonist therapies such as methadone or buprenorphine, Naltrexone provides a non‑opioid, antagonist approach that blocks opioid effects rather than substituting them. This can be advantageous for patients seeking an opioid‑free regimen but may require complete detoxification before initiation.

Naltrexone Accord should be stored at ambient temperature, below 25 °C, in its original container, protected from moisture and direct sunlight. Keep the product out of reach of children and do not use if the packaging is damaged.

Naltrexone Accord is taken orally, usually as a tablet or capsule, with or without food as directed by the prescriber. The medication should be swallowed whole with a glass of water and not crushed or chewed unless specifically instructed.

The most serious risks include potential hepatotoxicity, severe allergic reactions such as anaphylaxis, and the emergence of depression or suicidal thoughts. Patients should be monitored regularly for liver function and mood changes, and any severe symptoms should prompt immediate medical attention.

Naltrexone is contraindicated in individuals with acute hepatitis, severe liver impairment, or those currently dependent on opioid analgesics without having completed detoxification, as it can precipitate withdrawal. It should also be used with caution in patients with renal impairment and those with a history of severe depression.